|
Alcoholics Anonymous Affiliation at Treatment Intake among White and Black Americans(*).(Statistical Data Included)
From:
Journal of Studies on Alcohol
| Date:
November 1, 1999| Author:
HUMPHREYS, KEITH; KASKUTAS, LEE ANN; LEE, MIJA; WEISNER, CONSTANCE
| COPYRIGHT 1999 Alcohol Research Documentation, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
Objective: Black Americans are overrepresented in the public alcohol treatment system, but may be less likely to use informal services such as Alcoholics Anonymous (AA). Some commentators perceive AA as a white, middle-class organization that is unlikely to appeal to blacks. This epidemiological study considers prior attendance and engagement in AA among 791 black and white men and women entering treatment in public, private and HMO substance abuse programs. Method: Clients were interviewed...
Related newspaper, magazine, and journal articles from HighBeam Research
|
Alcoholics Anonymous Affiliation at Treatment Intake among White and Black Americans(*).(Statistical Data Included)
Journal of Studies on Alcohol
; THERE IS considerable interplay between the self-help sector and formal alcohol treatment system. For example, many treatment programs introduce their clients to the self-help group Alcoholics Anonymous (AA) and recommend AA as part of aftercare (Denzin, 1987; Makela et al., 1996), and many
|
|
Tests offer good news about a Vertex drug
The Boston Globe
; MONEY & MARKETS / MASS. MOVERS Vertex Pharmaceuticals Inc. says patients who failed on a common hepatitis C drug regimen responded when its telaprevir drug was added to their regimen; 115 previously treated patients were given telaprevir plus two standard drugs, Pegasys and ribavirin, for 12 weeks,
|
|
Novartis' Tasigna.(Pipeline)
Medical Marketing & Media
; Novartis' Tasigna (nilotinib) was approved in the US as a new anti-cancer therapy for certain patients with a life-threatening form of leukemia who are resistant or intolerant to prior treatment including Glivec (imatinib).
|
|
Tsongas stable following surgery
The Boston Globe
; Former US Sen. Paul Tsongas was in stable condition yesterday at Brigham and Women's Hospital following surgery Friday for liver complications related to his prior treatment for cancer, according to a hospital spokeswoman. Tsongas was admitted to the hospital about two weeks ago. He was diagnosed
|
|
Outrageous; Barbara Bishop, Hillsboro
Concord Monitor
; Outrageous I am outraged that your Jan. 31 headlines focused on the fact that Kristen Roy, who it appears has been killed in a domestic assault, may have been in a detox facility. This fact, if it is true, has no bearing on her death, and the fact that it would be listed as a headline clearly shows
|
|
Blumenfeld: Seasons in Hell
Opera News
; ... any potential dramatic impetus the work might have had. This recording is based on the stage production -- reviewed in OPERA NEWS, April 13, 1996 - by the opera department of the College-Conservatory of Music in Cincinnati under the baton of Gerhard Samuel ...
|
|
Substance-abusing child welfare parents: Treatment and child placement outcomes
Child Welfare
; The authors present findings from their study of 167 child welfare parents referred for substance abuse assessments. Relationships between gender, prior treatment, court-ordered intervention, significant others' support, and treatment and placement outcomes are examined. Findings indicate
|
|
HEALTH BRIEFS; Clinical trail; Heart health
The Patriot Ledger Quincy, MA
; Patients are needed for a clinical trial to test a new drug for age-related macular degeneration. Potential candidates must be 50 or over and have not had prior treatment for AMD. Trials will be conducted at Opthalmic Consultants of Boston and New England Eye Center at Tufts University. To find out
|
|
Extruder.(Brochures)
Rubber World
; The company's twin taper screw extruders are highlighted in a 20-page brochure. The firm's 2TE, SPM and FR under-mixer extruders are said to efficiently process materials discharged from the mixer into slabs, sheets or pellets. The MS-type twin taper screws permit all these models to charge
|
|
Point Therapeutics Clinical Update - Final
Fair Disclosure Wire
; ... now just summarize the key milestones and news flow that we'll be reporting on in 2006 ... provided, however, that members of the news media may redistribute limited portions ... provided, however, that members of the news media may redistribute limited portions ...
|